Does PONATINIB Cause Malignant neoplasm progression? 119 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Malignant neoplasm progression have been filed in association with PONATINIB (Iclusig). This represents 1.2% of all adverse event reports for PONATINIB.
119
Reports of Malignant neoplasm progression with PONATINIB
1.2%
of all PONATINIB reports
24
Deaths
30
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PONATINIB?
Of the 119 reports, 24 (20.2%) resulted in death, 30 (25.2%) required hospitalization, and 3 (2.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PONATINIB. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does PONATINIB Cause?
Death (1,735)
Off label use (1,071)
Product dose omission issue (817)
Fatigue (687)
Rash (639)
Headache (553)
Pyrexia (542)
Nausea (466)
Hospitalisation (459)
Constipation (435)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which PONATINIB Alternatives Have Lower Malignant neoplasm progression Risk?
PONATINIB vs PONATINIB\PONATINIB
PONATINIB vs PONESIMOD
PONATINIB vs PORACTANT ALFA
PONATINIB vs PORFIMER
PONATINIB vs POSACONAZOLE